Current evidence indicates that PRP can ameliorate T2DM alongside improving glucose and lipid profiles; this effect is predominantly linked to its modulation of the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.